Skip to main content
TipRanks
Go Ultimate75% OFF

Longevity Health Holdings (XAGE) Ratios

96 Followers

Longevity Health Holdings Ratios

XAGE's free cash flow for Q2 2026 was $-223.88K. For the 2026 fiscal year, XAGE's free cash flow was increased by $0.00 and operating cash flow was $-223.88K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.250.161.630.080.01
Quick Ratio0.120.141.630.080.01
Cash Ratio0.090.030.080.020.05
Solvency Ratio-0.81-1.64-0.39-0.22-0.20
Operating Cash Flow Ratio-0.42-0.75-0.22-0.47-0.07
Short-Term Operating Cash Flow Coverage-17.53-18.20-6.48-1.23-0.14
Net Current Asset Value$ -6.28M$ -5.23M$ 23.70M$ -38.93M$ -30.96M
Leverage Ratios
Debt-to-Assets Ratio0.210.430.032.146.22
Debt-to-Equity Ratio-0.09-0.140.09-0.10-0.33
Debt-to-Capital Ratio-0.09-0.160.08-0.11-0.49
Long-Term Debt-to-Capital Ratio0.000.000.000.00-0.00
Financial Leverage Ratio-0.40-0.312.58-0.05-0.05
Debt Service Coverage Ratio-32.05-35.86-6.98-0.78-0.01
Interest Coverage Ratio-390.23-101.98-5.87-1.47-0.19
Debt to Market Cap0.370.000.000.000.00
Interest Debt Per Share0.300.030.150.380.62
Net Debt to EBITDA0.03-0.050.05-0.71-102.14
Profitability Margins
Gross Profit Margin57.23%87.37%0.00%0.00%0.00%
EBIT Margin-358.15%-21262.23%0.00%0.00%0.00%
EBITDA Margin-346.91%-20870.20%0.00%0.00%0.00%
Operating Profit Margin-371.58%-9933.82%0.00%0.00%0.00%
Pretax Profit Margin-359.11%-21359.64%0.00%0.00%0.00%
Net Profit Margin-361.00%-20605.47%0.00%0.00%0.00%
Continuous Operations Profit Margin-361.00%-21166.31%0.00%0.00%0.00%
Net Income Per EBT100.53%96.47%95.31%100.00%1966.99%
EBT Per EBIT96.64%215.02%310.61%164.34%70.47%
Return on Assets (ROA)-291.73%-703.42%-24.15%-517.65%-416.09%
Return on Equity (ROE)117.70%220.01%-62.41%23.95%21.91%
Return on Capital Employed (ROCE)128.08%113.53%-20.50%99.30%3.28%
Return on Invested Capital (ROIC)135.02%121.59%-19.41%208.67%8.46%
Return on Tangible Assets-293.60%-712.92%-24.16%-526.29%-425.16%
Earnings Yield-1332.22%-5.93%-0.65%-0.15%-0.11%
Efficiency Ratios
Receivables Turnover52.410.160.000.000.00
Payables Turnover0.180.000.030.110.00
Inventory Turnover0.850.060.000.000.00
Fixed Asset Turnover4.760.100.000.000.00
Asset Turnover0.810.030.000.000.00
Working Capital Turnover Ratio-0.350.010.000.000.00
Cash Conversion Cycle-1568.90-224542.77-12920.24-3218.380.00
Days of Sales Outstanding6.962219.200.000.000.00
Days of Inventory Outstanding429.696241.520.000.000.00
Days of Payables Outstanding2005.56233003.4912920.243218.380.00
Operating Cycle436.658460.720.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.93-0.21-0.40-0.17-0.06
Free Cash Flow Per Share-1.94-0.21-0.40-0.17-0.06
Dividend Paid and CapEx Coverage Ratio-234.040.00-273.98-478.60-161.81
Capital Expenditure Coverage Ratio-234.040.00-273.98-478.60-161.81
Operating Cash Flow Coverage Ratio-6.66-6.87-3.91-0.92-0.12
Operating Cash Flow to Sales Ratio-1.74-87.220.000.000.00
Free Cash Flow Yield-645.05%-2.51%-0.35%-0.06%-0.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.08-16.74-153.72-649.99-880.60
Price-to-Sales (P/S) Ratio0.273477.450.000.000.00
Price-to-Book (P/B) Ratio-0.09-37.1395.93-155.68-192.90
Price-to-Free Cash Flow (P/FCF) Ratio-0.16-39.87-283.37-1712.30-4818.28
Price-to-Operating Cash Flow Ratio-0.16-39.87-284.41-1715.88-4848.06
Price-to-Earnings Growth (PEG) Ratio-0.000.52-3.20-0.140.00
Enterprise Value Multiple-0.05-16.71-156.24-1163.51-65490.57
Enterprise Value311.47K175.46M2.37B5.89B5.71B
EV to EBITDA-0.05-16.71-156.24-1163.51-65490.57
EV to Sales0.163487.020.000.000.00
EV to Free Cash Flow-0.09-39.98-283.28-1713.35-4825.81
EV to Operating Cash Flow-0.09-39.98-284.31-1716.93-4855.63
Tangible Book Value Per Share-3.41-0.231.19-1.91-1.50
Shareholders’ Equity Per Share-3.41-0.231.19-1.91-1.50
Tax and Other Ratios
Effective Tax Rate-0.010.010.000.000.00
Revenue Per Share1.110.000.000.000.00
Net Income Per Share-4.01-0.50-0.74-0.46-0.33
Tax Burden1.010.960.951.0019.67
Interest Burden1.001.001.061.711.00
Research & Development to Revenue0.4120.950.000.000.00
SG&A to Revenue3.8377.600.000.000.00
Stock-Based Compensation to Revenue0.3616.440.000.000.00
Income Quality0.480.370.540.380.18

Currency in USD